P. White
Oct 1, 2002
Citations
5
Influential Citations
98
Citations
Quality indicators
Journal
Anesthesia and analgesia
Abstract
Droperidol is a butyrophenone that was approved by the U.S. Food and Drug Administration (FDA) for clinical use as an antiemetic and as an adjuvant during general anesthesia (as part of a neuroleptic anesthetic technique) in 1970 (1). Yet, in December 2001, the FDA mandated that the manufacturer of